Myeloma
CAR T-Cell Therapy Approved for Heavily Pretreated Multiple Myeloma
The FDA approved the chimeric antigen receptor T-cell Carvykti, which showed a complete response in more than 80% ...
MARCH 1, 2022
Daratumumab Combination Improves PFS in Multiple Myeloma
At ASCO, daratumumab combination boosts survival in patients with previously treated multiple myeloma.
JUNE 10, 2016
Load more